Cargando…
Plasmacytoma of the Skull-base: A Rare Tumor
Plasmacytoma of the skull-base is a rare entity. Differential diagnosis includes chordoma, osteosarcoma, carcinoma nasopharynx, meningioma, metastatic carcinoma, lymphoma, and multiple myeloma. Accurate and precise diagnosis is extremely important for plasmacytoma of the skull-base as its treatment...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854301/ https://www.ncbi.nlm.nih.gov/pubmed/29552435 http://dx.doi.org/10.7759/cureus.2073 |
_version_ | 1783306888850440192 |
---|---|
author | Siyag, Abhilasha Soni, Tej P Gupta, Anil K Sharma, Lalit M Jakhotia, Naresh Sharma, Shantanu |
author_facet | Siyag, Abhilasha Soni, Tej P Gupta, Anil K Sharma, Lalit M Jakhotia, Naresh Sharma, Shantanu |
author_sort | Siyag, Abhilasha |
collection | PubMed |
description | Plasmacytoma of the skull-base is a rare entity. Differential diagnosis includes chordoma, osteosarcoma, carcinoma nasopharynx, meningioma, metastatic carcinoma, lymphoma, and multiple myeloma. Accurate and precise diagnosis is extremely important for plasmacytoma of the skull-base as its treatment and prognosis is different from other skull-base lesions. A 41-year-old man presented with concerns of headache, diplopia, and left eye strabismus. A magnetic resonance image (MRI) of his brain showed a large expansile mass measuring 51 mm involving the clivus and central skull-base. Trans-sphenoidal tumor decompression was done. A biopsy confirmed the plasmacytoma. A positron emission tomography-computed tomography (PET-CT) scan showed a single 2-(18F) fluoro-D-glucose (FDG) avid lesion at the skull-base. The results of all other relevant investigations such as hemoglobin, renal function test, serum calcium, serum protein immunoelectrophoresis, serum quantitative immunoglobulin, bone marrow biopsy, serum lactate dehydrogenase, and beta-2 microglobulin levels were within normal limits. He was treated with radical radiotherapy. He developed complete clinical response after radiotherapy. |
format | Online Article Text |
id | pubmed-5854301 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-58543012018-03-16 Plasmacytoma of the Skull-base: A Rare Tumor Siyag, Abhilasha Soni, Tej P Gupta, Anil K Sharma, Lalit M Jakhotia, Naresh Sharma, Shantanu Cureus Radiation Oncology Plasmacytoma of the skull-base is a rare entity. Differential diagnosis includes chordoma, osteosarcoma, carcinoma nasopharynx, meningioma, metastatic carcinoma, lymphoma, and multiple myeloma. Accurate and precise diagnosis is extremely important for plasmacytoma of the skull-base as its treatment and prognosis is different from other skull-base lesions. A 41-year-old man presented with concerns of headache, diplopia, and left eye strabismus. A magnetic resonance image (MRI) of his brain showed a large expansile mass measuring 51 mm involving the clivus and central skull-base. Trans-sphenoidal tumor decompression was done. A biopsy confirmed the plasmacytoma. A positron emission tomography-computed tomography (PET-CT) scan showed a single 2-(18F) fluoro-D-glucose (FDG) avid lesion at the skull-base. The results of all other relevant investigations such as hemoglobin, renal function test, serum calcium, serum protein immunoelectrophoresis, serum quantitative immunoglobulin, bone marrow biopsy, serum lactate dehydrogenase, and beta-2 microglobulin levels were within normal limits. He was treated with radical radiotherapy. He developed complete clinical response after radiotherapy. Cureus 2018-01-15 /pmc/articles/PMC5854301/ /pubmed/29552435 http://dx.doi.org/10.7759/cureus.2073 Text en Copyright © 2018, Siyag et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Radiation Oncology Siyag, Abhilasha Soni, Tej P Gupta, Anil K Sharma, Lalit M Jakhotia, Naresh Sharma, Shantanu Plasmacytoma of the Skull-base: A Rare Tumor |
title | Plasmacytoma of the Skull-base: A Rare Tumor |
title_full | Plasmacytoma of the Skull-base: A Rare Tumor |
title_fullStr | Plasmacytoma of the Skull-base: A Rare Tumor |
title_full_unstemmed | Plasmacytoma of the Skull-base: A Rare Tumor |
title_short | Plasmacytoma of the Skull-base: A Rare Tumor |
title_sort | plasmacytoma of the skull-base: a rare tumor |
topic | Radiation Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854301/ https://www.ncbi.nlm.nih.gov/pubmed/29552435 http://dx.doi.org/10.7759/cureus.2073 |
work_keys_str_mv | AT siyagabhilasha plasmacytomaoftheskullbaseararetumor AT sonitejp plasmacytomaoftheskullbaseararetumor AT guptaanilk plasmacytomaoftheskullbaseararetumor AT sharmalalitm plasmacytomaoftheskullbaseararetumor AT jakhotianaresh plasmacytomaoftheskullbaseararetumor AT sharmashantanu plasmacytomaoftheskullbaseararetumor |